BCG-vaccine (SSI)

PreclinicalVaccine

RRadboud University Medical Center

BCG-vaccine (SSI) is one of 2 biologic programs targeting Immunity. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ImmunityCompleted

ImmunityPreclinical

Completed

Competition

Competitive Landscape

2 competitors in Immunity

#DrugCompanyPhaseTrials

Ervebo

AANRS, Emerging Infectious Diseases

Phase 3

1 2

BCG-vaccine (SSI)

RRadboud University Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Vaccination1 trial

Influence of BCG on TDaP-IPV Vaccination

Unknown status·RRadboud University Medical Center·Phase 4·NCT02771782·75 enrolled

Immunity1 trial

γ-irradiated BCG to Train Innate Immunity

Completed·RRadboud University Medical Center·N/A·NCT02259608·15 enrolled

Immunogenicity1 trial

Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination

Completed·MMark Hatherill·Phase 2·NCT01650389·248 enrolled

Tuberculosis1 trial

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Terminated·GGates Medical Research Institute·Phase 2·NCT04152161·1,836 enrolled

Morbidity1 trial

Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.

Completed·LLone Graff Stensballe·Phase 4·NCT01694108·4,262 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for BCG-vaccine (SSI). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BCG-vaccine (SSI) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BCG-vaccine (SSI). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Radboud University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: RRadboud University Medical Center

BCG-vaccine (SSI)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Vaccination1 trial

Immunity1 trial

Immunogenicity1 trial

Tuberculosis1 trial

Morbidity1 trial

References

Drug Info

Quick Facts

Related News